Potential Biomarkers for NSAID-Exacerbated Respiratory Disease
Asthma is a common chronic disease with several variant phenotypes and endotypes. NSAID-exacerbated respiratory disease (NERD) is one such endotype characterized by asthma, chronic rhinosinusitis (CRS) with nasal polyps, and hypersensitivity to aspirin/cyclooxygenase-1 inhibitors. NERD is more assoc...
Saved in:
| Main Authors: | Hanki Park, Youngwoo Choi, Chang-Gyu Jung, Hae-Sim Park |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2017/8160148 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extracellular vesicle as biomarkers in NSAID‐exacerbated respiratory disease
by: Isaac Kirubakaran Sundar
Published: (2025-02-01) -
Radiological score, asthma and NSAID‐exacerbated respiratory disease predict relapsing chronic rhinosinusitis
by: Markus Lilja, et al.
Published: (2025-04-01) -
Factors affecting upper airway control of NSAID‐exacerbated respiratory disease: A real‐world study of 167 patients
by: Annina Lyly, et al.
Published: (2021-03-01) -
Critical pathomechanisms of NSAID-exacerbated respiratory disease (N-ERD) clarified by treatment with omalizumab, an anti-IgE antibody
by: Hiroaki Hayashi, et al.
Published: (2025-01-01) -
Dupilumab treatment has no effect on the nasal microbiome in patients with NSAID-exacerbated respiratory disease: a longitudinal pilot study
by: Tina Bartosik, et al.
Published: (2025-05-01)